Login / Signup

Reversal of hypercoagulability in patients with HCV-related cirrhosis after treatment with direct-acting antivirals.

Francesco Paolo RussoAlberto ZanettoElena CampelloCristiana BulatoSarah ShalabyLuca SpieziaSabrina GavassoEnrica FranceschetClaudia RaduMarco SenzoloPatrizia BurraJ P LuyendykPaolo Simioni
Published in: Liver international : official journal of the International Association for the Study of the Liver (2018)
DAAs therapy in HCV-related cirrhotic patients is associated with significant changes in thrombin generation suggesting a reversal of hypercoagulability particularly in Child's A patients.
Keyphrases
  • end stage renal disease
  • ejection fraction
  • newly diagnosed
  • hepatitis c virus
  • chronic kidney disease
  • prognostic factors
  • mental health
  • human immunodeficiency virus
  • drug induced